Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Hiscox (HSX.L)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (p) Price Target (p) Rating
2023-05-1711571575Buy
2023-07-1210821550Buy
2023-08-1010751530Buy
2023-11-089791560Buy
2024-02-0710361500Buy
2024-03-0511811550Buy
2024-08-0911671510Buy
2024-10-2211321495Buy
2024-11-1110601515Buy
2025-03-1411171465Buy
2025-05-0111091450Buy
2025-06-0413101595Buy
2025-08-0713441700Buy
2025-10-1713381675Buy
2026-02-2515391725Buy
2026-05-1316261850Buy
2026-07-0218512100Buy

Disclosures

  • UBS beneficially owned 1% or more of a class of this company's common equity securities as of last month's end (or the prior month's end if this report is dated less than 10 days after the most recent month's end).
  • UBS holds a long position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.